Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Breast Cancer Research

Fig. 1

From: Roles of BCCIP deficiency in mammary tumorigenesis

Fig. 1

BCCIP protein expression in normal mammary glands and breast cancers. BCCIP is stained brown, and nuclei are counterstained dark blue with hematoxylin. Percentages of BCCIP nuclear staining positive cells in the tumor region were recorded and arbitrarily divided into four groups: high expression, > 40% positive cells; moderate expression, 10–40% positive cells; low expression, 5–10% positive cells; BCCIP negative, < 5% positive cells. a Section of normal breast tissue at low magnification with an enlarged image of the boxed area. b Representative case of BCCIP positively stained breast cancer. c Representative case with moderate BCCIP staining. d, e Representative cases with low or negative BCCIP staining. BCCIP BRCA2 and CDKN1A interacting protein

Back to article page